Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Tubercidin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1

Interventions

Rituximab 111 Cyclophosphamide 100 fludarabine 59 Doxorubicin 32 Etoposide 31 Vincristine 30 Prednisone 30 Lenalidomide 24 ibrutinib 22 fludarabine phosphate 21 obinutuzumab 18 Immunotherapy, Adoptive 18 Cytarabine 18 Bendamustine Hydrochloride 18 pembrolizumab 16 Magnetic Resonance Spectroscopy 15 Bortezomib 14 polatuzumab vedotin 12 Specimen Handling 12 Dexamethasone 12 CT-P10 12 venetoclax 11 Gemcitabine 11 Carboplatin 11 pirtobrutinib 10 glofitamab 10 zanubrutinib 9 Nivolumab 9 Mycophenolic Acid 9 Melphalan 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05991388 2026-02-20

Glo-BNHL

University of Birmingham

Phase 2/3 Recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡